Docterz Raises ₹5 Crore, With Doctor-Users Contributing Nearly 60% of the Funding

Docterz has raised ₹5 crore, with doctor-users contributing almost 60%, to grow its healthcare technology platform and build practical AI tools.

Related: Enterprise AI startup Ema raises $77 million in Series B funding led by Creaegis

Docterz, a healthcare technology company based in Mumbai, has secured ₹5 crore from around 35 investors. Significantly, about 20 doctors who use the platform invested close to ₹3 crore, which amounts to nearly 60% of the total funding.

Founded by practising paediatrician Dr Atish Laddad, Docterz creates digital tools that assist doctors in managing clinics, patient records and routine administrative work. The most recent funding round also features Vineeta Singh, co-founder and CEO of SUGAR Cosmetics, along with Avnish Anand, co-founder and former CEO of CaratLane.

What makes this funding round especially notable is the involvement of doctor-users. These investors are already familiar with the platform and grasp the challenges it is designed to address. Their investment thus signals confidence in both the product and its capacity to support medical practitioners.

Docterz intends to use the funds to grow its business, pursue strategic acquisitions and roll out practical artificial intelligence (AI) tools for the medical community.

A key highlight of the funding round is the participation of doctors who rely on Docterz in their everyday practice.

About 20 doctors who use the platform invested roughly ₹3 crore in the company. Overall, around 35 investors took part in the ₹5 crore round.

Such a high level of participation underscores how much user trust matters in healthcare technology. Doctors depend on clinical software to handle sensitive patient data, schedule appointments and keep accurate medical records. As a result, usability, reliability and data security are crucial.

What Makes Doctor Involvement So Significant?

When customers put money into a company, they contribute more than just financial backing. They can also offer practical feedback drawn from their day-to-day experience.

At Docterz, doctor-investors grasp the difficulties involved in running a medical practice. They can assist the company in spotting areas where technology can save time and make workflows simpler.

In addition, their ongoing use of the platform can help Docterz learn what is working well and where improvements are required.

Still, user investment by itself does not ensure success in the future. The company needs to keep enhancing its product, safeguard patient data and show value to a broader medical community.

This ₹5 crore funding round brings together medical professionals and seasoned entrepreneurs.

The group of investors comprises:

• Vineeta Singh: Co-founder and CEO of SUGAR Cosmetics.
• Avnish Anand: Co-founder and former CEO of CaratLane.
• About 20 doctor-users: Medical practitioners who are already using Docterz.
• Other investors: Further participants, bringing the total number of investors to roughly 35.

By combining healthcare professionals with business leaders, Docterz gains access to varied perspectives on growth, product development and customer needs.

What Prompted Vineeta Singh to Invest in Docterz?

Vineeta Singh pointed to customer confidence as a major factor behind her decision to back the company. She observed that customers who put their own money into a business show a strong degree of trust.

She further voiced her confidence in founder Dr Atish Laddad, who created technology to solve problems within his own professional community.

This view mirrors Docterz’s philosophy: build technology around what doctors genuinely need instead of making practitioners adjust to complex systems.

Dr Atish Laddad started Docterz after seeing firsthand the challenges of running a medical practice as a paediatrician.

Physicians have to concentrate on caring for patients while simultaneously managing documentation, appointments, billing, staff coordination and follow-ups. These administrative duties can consume time that would otherwise go to direct patient interaction.

Docterz seeks to ease this burden by offering an integrated digital platform.

Dr Laddad noted that the company’s goal is to become the obvious first choice for doctors looking for practical technology to run and grow their practices. He further highlighted patient data security, clinical independence and the doctor-patient relationship.

The founder intends to use the new funding to drive organic growth, pursue acquisitions and build AI tools that tackle everyday problems in medical practice.

What do doctor-investors have to say about the platform?

Dr Dhananjay Sangle, a paediatrician and Docterz investor, said he had used the software for several years across paediatric and OB-GYN practices. He pointed to its speed, ease of use and smooth workflow.

He also voiced confidence in Dr Laddad’s business capabilities and commitment to the medical community.

Likewise, Dr Suhas Warad, another paediatrician and investor, said technology built around doctors’ needs could help medical professionals run their practices more efficiently and spend more time on patient care.

These testimonials reflect the investors’ personal experiences. As the company grows, maintaining this trust will matter for attracting more doctors and healthcare organisations.

Established over ten years ago, Docterz offers an integrated platform for electronic medical records and practice management. According to the company, its technology serves over 5,000 doctors throughout India, with a notable focus on paediatrics.

This platform merges clinical and administrative functions into a single system.

Main Features of the Docterz Platform

• Electronic medical records: Enables doctors to keep patient histories and clinical documentation in digital form.
• Appointment management: Aids in scheduling and organising patient visits.
• Billing and payments: Assists clinics in handling billing-related workflows.
• Vaccination management: Aids in tracking vaccination records and associated follow-ups.
• Pharmacy and laboratory management: Links additional clinic operations together within the platform.
• Patient engagement: Aids communication and follow-up with patients.
• Analytics and teleconsultation: Offers tools for understanding practice performance and supporting remote consultations.

By bringing these features together, Docterz seeks to make everyday clinic management more convenient.

In addition, integrated software can lessen the need to switch between disconnected tools. This can help clinics organise information more effectively, as long as the systems stay reliable and easy to use.

Docterz intends to put the new capital toward expanding the business, developing products, and adopting new technology.

This funding will back three key priorities.

1. Grow Across India

Docterz seeks to reach more independent doctors, smaller clinics and healthcare organisations. These practitioners frequently require affordable, practical technology that works with their existing workflows.

By broadening its reach, the company hopes to help more medical professionals adopt digital tools for managing their practices.

2. Examine Acquisitions and Strategic Opportunities

In addition to organic growth, Docterz intends to investigate opportunities for inorganic expansion. This could involve acquisitions or strategic partnerships that enable it to reach additional customers or reinforce its product capabilities.

These opportunities might speed up growth. Nevertheless, successful expansion will hinge on selecting appropriate partners and integrating new operations effectively.

3. Create Practical AI Tools for Physicians

AI plays a central role in Docterz’s upcoming stage of growth. The company plans to launch tools that tackle routine clinical and administrative difficulties.

Possible areas of use cover documentation, workflow automation, practice analytics, and patient follow-up. Such tools may assist doctors in cutting down repetitive tasks and arranging information more efficiently.

The emphasis is on practical uses that align with existing medical workflows. AI ought to assist doctors instead of substituting for their professional judgement.

Since healthcare information is sensitive, the company must also make privacy, security, and responsible data use priorities as it builds new capabilities.

Healthcare professionals handle vast amounts of information, ranging from medical histories and prescriptions to appointment records and follow-up notes.

AI tools may assist in organising this information and lessen some repetitive administrative work. For instance, thoughtfully designed systems could help with drafting documentation, summarising records, or identifying patients who require follow-up.

These are, however, potential use cases, not a claim that every feature is currently offered on Docterz.

Any AI application in healthcare needs to be designed with suitable safeguards. Patient information must stay protected, and doctors must keep control over clinical decisions.

For Docterz, the opportunity is in building technology that saves time without sacrificing the quality of care or the relationship between doctors and patients.

Docterz likewise intends to keep building integrations with India’s digital-health ecosystem, such as the Ayushman Bharat Digital Mission (ABDM).

India’s digital-health programs are designed to enhance how healthcare information is managed and shared. Appropriate integrations can enable digital systems to collaborate more effectively, provided that applicable standards, consent requirements and security safeguards are met.

For independent clinics, technology that enables improved record management and interoperability could make the shift to digital easier.

As more healthcare providers adopt digital systems, Docterz’s emphasis on clinical software, patient engagement and AI could thus help it meet a broader range of needs.

Even so, the success of these initiatives will hinge on practical implementation, user adoption and the company’s capacity to uphold high standards of data protection.

This ₹5 crore funding round provides Docterz with extra resources to grow its platform and reinforce its standing in India’s healthcare technology market.

The participation of doctor-users matters greatly, since they know the product through firsthand experience. Their investment may also establish a useful feedback loop as the company builds new features.

At the same time, support from entrepreneurs like Vineeta Singh and Avnish Anand adds further business expertise to the investor group.

Docterz now intends to broaden its customer base, pursue strategic acquisitions and roll out practical AI tools. Its next challenge will be converting these plans into tangible improvements for doctors and healthcare organisations.

All in all, Docterz’s ₹5 crore fundraise stands out not only for the sum raised but also for who took part in it. As almost 60% of the capital comes from doctor-users, the round underscores how trust and real product value can help build healthcare technology.